全体基調セッション

Monday, May 4

PLENARY KEYNOTE SESSION: THE AGE OF ARTIFICIAL INTELLIGENCE: PRECISION MEDICINE VENTURE AND INNOVATION

8:35 am Chairperson's Remarks
Charity Williams, Partner, Cooley LLP

8:40 am Keynote Introduction (Sponsorship Opportunity Available)

8:45 am PLENARY KEYNOTE PANEL DISCUSSION: Tech Titans, Investors, and Innovators: How AI Is Driving Precision Medicine Forward

PANEL MODERATOR:
Charity Williams, Partner, Cooley LLP
Join leading venture investors and AI innovators as they explore how artificial intelligence is driving the next generation of personalized healthcare. This discussion will uncover emerging investment theses and the critical role of partnerships between technology platforms, startups, and providers in shaping the future of precision medicine.

PANELISTS:
Milad Alucozai, DrPH, Co-Founder & General Partner, Pamir Ventures
Noosheen Hashemi, Founder & CEO, January AI
Ujjwal Ratan, Head of ML and Data Science, Healthcare & Life Sciences, Amazon Web Services
Joe Shonkwiler, MD, Lead, Healthcare and Life Sciences, Venture Capital BD, Google

PLENARY KEYNOTE SESSION

3:50 pm Chairperson's Remarks
Mara G. Aspinall, Partner, Illumina Ventures;s; Professor of Practice, Arizona State University

3:55 pm Keynote Introduction (Sponsorship Opportunity Available)

4:00 pm Presentation to be Announced

4:30 pm PANEL DISCUSSION: The Tipping Point: CEOs on the Future of Precision Medicine

PANEL MODERATOR:
Mara G. Aspinall, Partner, Illumina Ventures; Professor of Practice, Arizona State University
As precision medicine accelerates across oncology, population health, and consumer diagnostics, industry leadership is critical to translating innovation into real-world impact. In this session, Mara Aspinall hosts a CEO panel for a candid discussion on the technologies reshaping early detection, decentralized testing, genomic architecture analysis, and the expanding role of AI in powering more accurate and accessible care. The panel will highlight the scientific, clinical, and commercial milestones that signal where precision medicine is headed next.

PANELISTS:
Lisa Alderson, CEO, Adela, Inc.
Julia Cheek, CEO and Founder, Everlywell

Tuesday, May 5

PLENARY KEYNOTE SESSION

8:30 am Chairperson's Remarks
Mara G. Aspinall, Partner, Illumina Ventures; Professor of Practice, Arizona State University

8:35 am Keynote Introduction (Sponsorship Opportunity Available)

8:40 am PLENARY KEYNOTE PANEL DISCUSSION: Intelligence & Impact: The Age of Diagnostic Innovation

PANEL MODERATOR:
Mara G. Aspinall, Partner, Illumina Ventures; Professor of Practice, Arizona State University
Diagnostics is entering a moment of rapid change, fueled by new technologies, evolving patient needs, and the growing influence of AI. In this keynote session, Mara hosts a panel of industry leaders to discuss how they are driving innovation within their own organizations-from advancing early detection to expanding decentralized testing and building smarter, AI-enabled laboratory systems. The conversation will explore the practical steps these leaders are taking today and what their efforts mean for patients, providers, and the future of the field.

PANELISTS:
William G. Morice II, MD, PhD, President & CEO, Mayo Clinic Laboratories; Professor & Past Chair, Department of Laboratory Medicine and Pathology, Mayo Clinic; Chair, American Clinical Laboratory Association Board of Directors
Jenny Rooke, PhD, Managing Director, Genoa Ventures
Ajit Singh, PhD, CEO, Harbinger Health
Megann Vaughn Watters, Vice President, New Ventures & Strategic Alliances, Labcorp